|
US6077850A
(en)
*
|
1997-04-21 |
2000-06-20 |
G.D. Searle & Co. |
Substituted benzopyran analogs for the treatment of inflammation
|
|
IT1296985B1
(it)
|
1997-12-19 |
1999-08-03 |
Zambon Spa |
Derivati benzazinici inibitori della fosfodiesterasi 4
|
|
US6093732A
(en)
*
|
1997-12-22 |
2000-07-25 |
Pharmacia & Upjohn Company |
4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
|
|
IT1302677B1
(it)
*
|
1998-10-15 |
2000-09-29 |
Zambon Spa |
Derivati benzazinici inibitori della fosfodiesterasi 4
|
|
US6248736B1
(en)
*
|
1999-01-08 |
2001-06-19 |
Pharmacia & Upjohn Company |
4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
|
|
US6248739B1
(en)
*
|
1999-01-08 |
2001-06-19 |
Pharmacia & Upjohn Company |
Quinolinecarboxamides as antiviral agents
|
|
HU229439B1
(hu)
|
1999-08-21 |
2013-12-30 |
Takeda Gmbh |
Roflumilast és salmeterol szinergetikus kombinációja
|
|
US6436971B2
(en)
*
|
2000-02-09 |
2002-08-20 |
Smithkline Beecham Corporation |
Use of PDE 4-specific inhibitors to reduce the severity of a bacterial infection after a respiratory viral infection
|
|
JP2003529601A
(ja)
|
2000-03-21 |
2003-10-07 |
ファルマシア・アンド・アップジョン・カンパニー |
抗ウイルス剤としての４−オキソ−１，４−ジヒドロ［１，８］ナフチリジン−３−カルボキサミド
|
|
CA2399991A1
(en)
|
2000-03-21 |
2001-09-27 |
Pharmacia & Upjohn Company |
4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
|
|
CN1398258A
(zh)
|
2000-03-21 |
2003-02-19 |
法玛西雅厄普约翰美国公司 |
用作抗病毒剂的4－羟基噌啉－3－甲酰胺化合物
|
|
IL151787A0
(en)
|
2000-03-21 |
2003-04-10 |
Upjohn Co |
4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents
|
|
PE20011349A1
(es)
*
|
2000-06-16 |
2002-01-19 |
Upjohn Co |
1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales
|
|
US6559145B2
(en)
|
2000-07-12 |
2003-05-06 |
Pharmacia & Upjohn Company |
Heterocycle carboxamides as antiviral agents
|
|
US6562822B2
(en)
|
2000-07-12 |
2003-05-13 |
Pharmacia & Upjohn Company |
Heterocyle carboxamides as antiviral agents
|
|
US6730682B2
(en)
*
|
2000-07-12 |
2004-05-04 |
Pharmacia & Upjohn Company |
Heterocycle carboxamides as antiviral agents
|
|
TWI243164B
(en)
|
2001-02-13 |
2005-11-11 |
Aventis Pharma Gmbh |
Acylated indanyl amines and their use as pharmaceuticals
|
|
PE20020856A1
(es)
|
2001-02-13 |
2002-11-11 |
Aventis Pharma Gmbh |
1,2,3,4-tetrahidronaftil aminas aciladas
|
|
JP2004520424A
(ja)
|
2001-03-01 |
2004-07-08 |
ファルマシア・アンド・アップジョン・カンパニー |
抗ウイルス剤としての置換型キノリンカルボキサミド
|
|
HUP0402310A2
(hu)
*
|
2001-09-26 |
2005-02-28 |
Bayer Pharmaceuticals Corporation |
1,6-Naftiridin-származékok mint antidiabetikumok és ezeket tartalmazó gyógyszerkészítmények
|
|
US7300926B2
(en)
*
|
2002-04-01 |
2007-11-27 |
University Of Florida Research Foundation, Inc. |
Steroidal quinols and their use for estrogen replacement therapy
|
|
US20070213310A1
(en)
*
|
2002-04-01 |
2007-09-13 |
Laszlo Prokai |
Prodrugs for Use as Ophthalmic Agents
|
|
PT1490392E
(pt)
*
|
2002-04-01 |
2007-04-30 |
Univ Florida |
Quinóis esteroidais como pró-fármacos de antioxidantes
|
|
US7186707B2
(en)
|
2002-04-01 |
2007-03-06 |
University Of Florida |
Prodrugs for use as ophthalmic agents
|
|
WO2004069248A1
(en)
*
|
2002-12-09 |
2004-08-19 |
University Of Florida |
Prodrugs for use a ophthalmic agents
|
|
WO2004087211A2
(en)
|
2003-04-01 |
2004-10-14 |
Applied Research Systems Ars Holding N.V. |
Inhibitors of phosphodiesterases in infertility
|
|
WO2005009971A1
(ja)
|
2003-07-24 |
2005-02-03 |
Astellas Pharma Inc. |
キノロン誘導体又はその塩
|
|
US7470706B2
(en)
*
|
2004-01-31 |
2008-12-30 |
Sanofi-Aventis Deutschland Gmbh |
Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
|
|
DE102004004971B3
(de)
*
|
2004-01-31 |
2005-09-15 |
Aventis Pharma Deutschland Gmbh |
Cycloalkyl substituierte 7-Amino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arnzeimittel
|
|
WO2005095327A1
(ja)
|
2004-03-31 |
2005-10-13 |
Ajinomoto Co., Inc. |
アニリン誘導体
|
|
NZ587549A
(en)
*
|
2004-06-24 |
2012-10-26 |
Vertex Pharma |
6-Amino-indole derivatives and processes for their preparation
|
|
EP3705477A1
(en)
*
|
2004-06-24 |
2020-09-09 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
|
RU2528046C2
(ru)
*
|
2004-06-24 |
2014-09-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Модуляторы транспортеров атф-связывающей кассеты
|
|
US8354427B2
(en)
|
2004-06-24 |
2013-01-15 |
Vertex Pharmaceutical Incorporated |
Modulators of ATP-binding cassette transporters
|
|
DE102004035203A1
(de)
|
2004-07-21 |
2006-02-16 |
Bayer Healthcare Ag |
Substituierte Chinolone
|
|
DE102005030524A1
(de)
|
2005-06-30 |
2007-01-18 |
Aicuris Gmbh & Co. Kg |
Substituierte Chinolone II
|
|
JP2009521468A
(ja)
*
|
2005-12-24 |
2009-06-04 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ａｂｃ輸送体の調節因子としてのキノリン−４−オン誘導体
|
|
EP1974212A1
(en)
*
|
2005-12-27 |
2008-10-01 |
Vertex Pharmaceuticals Incorporated |
Compounds useful in cftr assays and methods therewith
|
|
CA2635581C
(en)
|
2005-12-28 |
2017-02-28 |
Vertex Pharmaceuticals Incorporated |
Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
|
|
DE102006005861A1
(de)
|
2006-02-09 |
2007-08-23 |
Aicuris Gmbh & Co. Kg |
Substituierte Chinolone III
|
|
ES2427247T3
(es)
*
|
2006-03-13 |
2013-10-30 |
Kyorin Pharmaceutical Co., Ltd. |
Aminoquinolonas como inhibidores de GSK-3
|
|
US20100074949A1
(en)
|
2008-08-13 |
2010-03-25 |
William Rowe |
Pharmaceutical composition and administration thereof
|
|
US12458635B2
(en)
|
2008-08-13 |
2025-11-04 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition and administrations thereof
|
|
UA104601C2
(uk)
|
2008-10-23 |
2014-02-25 |
Вертекс Фармасьютікалз, Інкорпорейтед |
Модулятори регулятора трансмембранної провідності при муковісцидозі
|
|
PL2408750T3
(pl)
|
2009-03-20 |
2016-02-29 |
Vertex Pharma |
Sposób otrzymywania modulatorów błonowego regulatora przewodnictwa swoistego dla mukowiscydozy
|
|
US8802700B2
(en)
|
2010-12-10 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
|
AU2013226076B2
(en)
|
2012-02-27 |
2017-11-16 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition and administration thereof
|
|
GB201409044D0
(en)
|
2014-05-21 |
2014-07-02 |
Ucl Business Plc |
New compounds
|
|
KR20170063954A
(ko)
|
2014-10-07 |
2017-06-08 |
버텍스 파마슈티칼스 인코포레이티드 |
낭성 섬유증 막횡단 전도도 조절자의 조정제의 공-결정
|
|
CN107998131B
(zh)
*
|
2017-12-27 |
2019-09-24 |
湖北工业大学 |
芳香酯类化合物用于制备抗adv-7病毒药物
|
|
CN111646941A
(zh)
*
|
2020-07-17 |
2020-09-11 |
天津科技大学 |
一种磺酰胺类衍生物及其制备方法和应用
|